Tag Page KRASG12C

Game-Changer for Tough Colon Cancer

Big news for anyone following cancer breakthroughs: a new drug combo (sotorasib + panitumumab) is showing major promise for colon cancer that’s stopped responding to chemo. In a recent trial, over 30% of patients on the high-dose combo saw their tumors shrink by half—way better than the current standard. Plus, patients lived longer, too. This could totally shake up how doctors treat KRAS G12C metastatic colorectal cancer! #CancerResearch #ColorectalCancer #MedicalBreakthrough #KRASG12C #CityOfHope #Health